KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Elevance Health (ELV) EBITDA Margin (2016 - 2025)

Elevance Health (ELV) has disclosed EBITDA Margin for 17 consecutive years, with 1.0% as the latest value for Q4 2025.

  • Quarterly EBITDA Margin fell 16.0% to 1.0% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.11% through Dec 2025, down 10.0% year-over-year, with the annual reading at 1.11% for FY2025, 5.0% down from the prior year.
  • EBITDA Margin for Q4 2025 was 1.0% at Elevance Health, down from 1.23% in the prior quarter.
  • The five-year high for EBITDA Margin was 2.25% in Q4 2022, with the low at 0.91% in Q1 2021.
  • Average EBITDA Margin over 5 years is 1.16%, with a median of 1.15% recorded in 2021.
  • The sharpest move saw EBITDA Margin soared 117bps in 2021, then tumbled -104bps in 2023.
  • Over 5 years, EBITDA Margin stood at 1.14% in 2021, then skyrocketed by 97bps to 2.25% in 2022, then crashed by -46bps to 1.21% in 2023, then dropped by -4bps to 1.16% in 2024, then fell by -14bps to 1.0% in 2025.
  • According to Business Quant data, EBITDA Margin over the past three periods came in at 1.0%, 1.23%, and 0.98% for Q4 2025, Q3 2025, and Q2 2025 respectively.